Skip to main content

Ɔltin bɔt di Abrocitinib pil fɔ yu skin sik insay simpul wɔd dɛn

Ɔltin bɔt di Abrocitinib pil fɔ yu skin sik insay simpul wɔd dɛn

Sɔntɛnde, sik dɛn na di skin kin rili vɛks, nɔto so? Ɛspɛshali fɔ pɔrsin wae gɛt wan sik lɛk Atopic Dermatitis, dɛn no aw e tranga. E nɔr izi fɔ liv wit ɔltɛm it, rɛd, ɛn pen. So, wan nyu kayn mɛrɛsin wae dɔktɔ dɛn kin gi fɔ trit dis sik na in dɛn kɔl Abrocitinib. Tide, wi go tɔk bɔt dis mɛrɛsin, aw i de wok, tin dɛn we wi fɔ tek tɛm wit, ɛn di sayd ɛfɛkt dɛn, rili simpul wan, insay wi langwej.

Wetin na Abrocitinib?

Fɔ tɔk am simpul wan, Abrocitinib na wan pil we dɛn kin yuz fɔ mɛn atɔpik dɛmatitis. Yu kin sabi am wit di brand nem CIBINQO.

Dis drɔg de pan wan klas ɔf drɔgs we dɛn kɔl JAK inhibitors. Tink bɔt am dis we: di imyun sistɛm na wi bɔdi tan lɛk ami we de protɛkt wi frɔm sik. Bɔt pan kɔndishɔn lɛk atɔpik dɛmatitis, dis ami kin tu aktif smɔl ɛn atak wi yon skin. JAK inhibito dεm de wok bay we dεn de kכntrכl dis כva aktiv aktiviti εn rεdכks inflameshn, it, εn rεdnes na di skin. Dat min se, dεn kin kכl dכn di imyun sistεm in rεspכns we i nכ want.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin fɔ tek mɛrɛsin

Dis rili impɔtant. Bifo yu disayd if abrocitinib fayn fɔ yu, yu dɔktɔ go nid fɔ no yu kɔmplit mɛdikal istri. Mek shɔ se yu tɛl yu dɔktɔ if yu gɛt ɛni wan pan dɛn tin ya:

Sik ɔ kɔndishɔn Speshal pɔynt dɛn we wi fɔ no bɔt
Infεkshכn stetכs Infεkshכn dεm we de kכmכt כ we de kam bak (e.g., chikinpoks, hεpi, TB (TB), fεnshכn כ baktriyal infεkshכn).
At sik ɛn prɔblɛm wit di blɔd vesel At sik, ay blɔd prɛshɔn, ay kɔlɔstrel, istri bɔt blɔd klɔt, strok.
Kansa If yu bin dɔn gɛt kansa bifo ɔ yu de gɛt tritmɛnt naw.
Ɔda tin dɛn we kin apin to pɔsin we sik Dayabitis, kidni ɔ liva sik, lɔng sik (asma, COPD), yay sik (e.g. katarakt), blɔd sɛl dɛn we nɔ de bɔku (rɛd, wayt, pletlɛt).
Pɔsin in yon ɛn di we aw i de liv in layf If yu gɛt bɛlɛ, yu de tray fɔ gɛt bɛlɛ, ɔ yu de gi pikin in bɛlɛ. If yu de smok. If yu jɔs gɛt di vaysin ɔ yu fɔ gɛt wan tumara bambay.
Alɛji dɛn we pɔsin kin gɛt If yu gɛt alɛji fɔ abrocitinib ɔ ɛni ɔda mɛrɛsin, it, ɔ day.

Aw ɛksaktɔli a kin yuz dis mɛrɛsin?

Fɔ mek yu gɛt di bɛst pan di mɛrɛsin, i rili impɔtant fɔ yuz am lɛk aw dɛn tɛl yu fɔ yuz am.

  • Dis na tablɛt we dɛn kin tek bay mɔt. Swɛla di tablɛt ɔl wit wan glas wata.
  • Di tin we impɔtant pas ɔl: Nɔ brok, krɔs, ɔ chew di tablɛt. Swɛla am ɔl.
  • Tray fɔ tek yu mɛrɛsin di sem tɛm ɛvride , jɔs lɛk aw yu dɔktɔ tɛl yu. Dis go ɛp fɔ kip di kɔnsɛntreshɔn fɔ di mɛrɛsin na yu blɔd na di sem lɛvɛl.
  • Yu kin tek dis bifo ɔ afta yu it. Bɔt if yu fil bad ɔ yu nɔs, tek di mɛrɛsin wit yu it.
  • Nɔ stɔp fɔ tek di mɛrɛsin te di dɔktɔ tɛl yu fɔ tek am.
  • Yu go gɛt spɛshal instrɔkshɔn liflet (`MedGuide`) wit dis mɛrɛsin frɔm di famasi. Rid am gud gud wan ɛvri tɛm.

Wetin fɔ du if yu mis wan doz fɔ mɛrɛsin?

If yu mis wan doz, tek am jɔs afta yu mɛmba. Bɔt if i nɔ rich 12 awa te yu tek yu nɛks doz we yu mɛmba, skip di doz we yu mis ɛn tek yu nɛks doz di tɛm we yu dɔn sɛtul. Nɔ ɛva tek tu dos wan tɛm.

Wetin a go du if a tek bɔku mɛrɛsin?

If yu tink se yu dɔn tek mɔ pas di doz we dɛn tɛl yu fɔ tek, nɔ delay. Wantɛm wantɛm, kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital , ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Ɔda mɛrɛsin dɛn we kin miks wit Abrocitinib

Sɔm mɛrɛsin dɛn kin afɛkt dɛnsɛf we dɛn tek dɛn togɛda. dis dεn kכl am `drug intarakshכn`. Na dat mek i rili impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek (inklud vaytamɛn, ɛbul mɛrɛsin, ɛn sɔpɔtmɛnt).

Mɛrɛsin dɛn we nɔ fɔ ɛva tek wit Abrocitinib

  • Abciximab we gɛt di sik
  • Anagrelide we dɛn kɔl
  • Silostazɔl we dɛn kɔl Cilostazol
  • Klɔpidogrɛl we dɛn kɔl
  • Dipiridamol we dɛn kɔl dipiridamol
  • Eptifibatide we dɛn kin yuz

  • Layf vaysin dɛn
  • Prasugrel we dɛn kɔl
  • Tikagrelɔr we dɛn kɔl
  • Tiklɔpidin we dɛn kɔl
  • Tirofiban we dɛn kɔl Tirofiban
  • Vorapaxar we de na di wɔl

Mɛrɛsin dɛn we dɛn fɔ tek ɔnda dɔktɔ advays nɔmɔ, bikɔs dɛn kin mek prɔblɛm.

  • Aspirin we dɛn kin yuz
  • Baricitinib, Tofacitinib, Upadacitinib (ɔda JAK inhibito dɛn) .
  • Bayolojikal mɛrɛsin dɛn (e.g. Adalimumab, Infliximab) .
  • Dabigatran we dɛn kɔl Dabigatran

  • Digoxin we dɛn kin yuz
  • Flukonazɔl we dɛn kɔl
  • Fluvoxamin we dɛn kɔl fluvoxamine
  • Rifampin bin de du am
  • Ɔda mɛrɛsin dɛn we de mek pɔsin nɔ ebul fɔ fɛt di sik

Impɔtant: Dis list nɔ kɔmplit. So, tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek.

Tin dɛn we yu fɔ tek tɛm wit mɔ we yu de tek di mɛrɛsin

  • Fɔ chɛk yu dɔktɔ ɔltɛm: Yu dɔktɔ go tɛl yu fɔ go to yu dɔktɔ ɔltɛm fɔ wach aw yu de fil ɛn aw yu mɛrɛsin de afɛkt yu. I go ɔda bak fɔ mek dɛn du blɔd tɛst fɔ chɛk tin dɛn lɛk yu blɔd sɛl dɛn ɛn di kɔlɔstrel lɛvɛl. Nɔ skip dɛn.
  • Risk fɔ infekshɔn: As wi bin dɔn tɔk, bikɔs dis mɛrɛsin de stɔp di imyun sistɛm, .Di risk fɔ gɛt infɛkshɔn kin bɔku. If yu gɛt sɔm kayn sik lɛk fiva, kol, kɔf, trot we de at, ɔ wund we nɔ de wɛl, nɔ fɔ mɛn yusɛf ɛn kɔl yu dɔktɔ wantɛm wantɛm.
  • Fɔ protɛkt yusɛf frɔm di san: Yu skin kin fil bad fɔ di san we yu de tek dis mɛrɛsin. So, nɔ fɔ go na do usay di san de shayn bad bad wan. If yu go na do, wɛr klos we de kɔba yu skin ɛn yuz gud tin fɔ protɛkt yusɛf frɔm di san.
  • Risk fɔ gɛt kansa: Stɔdi dɔn sho se pipul dɛm wae de tek dis mɛrɛsin kin gɛt sɔm kayn kansa (especially skin cancer) ɛn lymphoma smɔl. Nɔr frayd fɔ dis, bɔt tɔk to yu dɔktɔ bɔt dis risk ɛn ɛni nyu skin spat we yu notis.
  • Bεlε εn bεlε: Nɔ gi bεlε we yu de tek dis mεrεsin εn fכ at le wan de afta yu stכp. I kin afɛkt bak aw yu ebul fɔ gɛt bɛlɛ. If yu de wɔri bɔt dis, tɔk to yu dɔktɔ.

Di sayd ɛfɛkt dɛn we di mɛrɛsin kin gɛt

Lɛk ɔl mɛrɛsin, Abrocitinib kin mek yu gɛt sayd ɛfɛkt, pan ɔl we nɔto ɔlman kin gɛt am.

Siriɔs sayd ɛfɛkt dɛn we nid fɔ go to dɔktɔ wantɛm wantɛm
Alɛji dɛn we pɔsin kin gɛt Skin rash, it, swel na di lip/tɔng/fes, i nɔ izi fɔ blo.
Blɔd we de klɔt Leg pen, swel, wam, shɔt briz, chɛst pen.
At atak Tayt na di chɛst, sholda, an, nɔs, shɔt briz, swet.
Strok Di fes, an, ɔ leg kin swɛ/wik wantɛm wantɛm, i nɔ kin izi fɔ tɔk, i kin kɔnfyus, i nɔ kin izi fɔ waka.
Liva injuri Pen na di ɔp rayt say na di bɛlɛ, yu nɔ de want fɔ it, yu yay/skin de yɔlɔ, ɛn yu urine dak.
Sayd ɛfɛkt dɛm wae nɔr kin siriɔs, bɔt yu fɔ ripɔt to yu dɔktɔ if dɛn de mɔna yu
Akni we gɛt akni Akni na di fes ɔ bɔdi.
Prɔblɛm dɛn we de na di dijestiv sistɛm Nɔs, vɔmit, bɛlɛ pen.
Trot de at Trot kin at ɔ nɔ kin fil fayn.

Mɛsej we dɛn kin kɛr go na os

  • Abrocitinib na spɛshal mɛrɛsin we de afɛkt di imyun sistɛm ɛn dɛn kin yuz am fɔ trit atopik dɛmatitis.
  • Bifo yu bigin dis mɛrɛsin, i impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl yu mɛrɛsin ɛn ɔda mɛrɛsin dɛn we yu de tek.
  • Swɛla di tablɛt ɔl wit wata we yu nɔ brok, krɔs, ɔ chew.
  • Go to dɔktɔ kwik kwik wan if yu gɛt ɛni siriɔs sayn lɛk sayn fɔ infekshɔn (fiva, kɔf), i nɔ izi fɔ blo, yu chɛst de pen, ɔ yu de si chenj wantɛm wantɛm.
  • I rili impɔtant fɔ protɛkt yusɛf frɔm di san we yu de tek di mɛrɛsin ɛn fɔ mek yu dɔktɔ tɛl yu fɔ du di blɔd tɛst di rayt tɛm.
  • Nɔ stɔp fɔ tek di mɛrɛsin ɔ chenj di doz if yu dɔktɔ nɔ advays yu. If yu gɛt ɛnitin we de mɔna yu, tɔk bɔt am wit yu dɔktɔ.

Abrocitinib, abrocitinib, cibinqo, atopik dɛmatitis, atɔpik dɛmatitis, ɛkzema, skin sik, JAK inhibito, sayd ɛfɛkt dɛm
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 4 + 4 =
Ɔltin bɔt di Abrocitinib pil fɔ yu skin sik insay simpul wɔd dɛn

Ɔltin bɔt di Abrocitinib pil fɔ yu skin sik insay simpul wɔd dɛn

Sɔntɛnde, sik dɛn na di skin kin rili vɛks, nɔto so? Ɛspɛshali fɔ pɔrsin wae gɛt wan sik lɛk Atopic Dermatitis, dɛn no aw e tranga. E nɔr izi fɔ liv wit ɔltɛm it, rɛd, ɛn pen. So, wan nyu kayn mɛrɛsin wae dɔktɔ dɛn kin gi fɔ trit dis sik na in dɛn kɔl Abrocitinib. Tide, wi go tɔk bɔt dis mɛrɛsin, aw i de wok, tin dɛn we wi fɔ tek tɛm wit, ɛn di sayd ɛfɛkt dɛn, rili simpul wan, insay wi langwej.

Wetin na Abrocitinib?

Fɔ tɔk am simpul wan, Abrocitinib na wan pil we dɛn kin yuz fɔ mɛn atɔpik dɛmatitis. Yu kin sabi am wit di brand nem CIBINQO.

Dis drɔg de pan wan klas ɔf drɔgs we dɛn kɔl JAK inhibitors. Tink bɔt am dis we: di imyun sistɛm na wi bɔdi tan lɛk ami we de protɛkt wi frɔm sik. Bɔt pan kɔndishɔn lɛk atɔpik dɛmatitis, dis ami kin tu aktif smɔl ɛn atak wi yon skin. JAK inhibito dεm de wok bay we dεn de kכntrכl dis כva aktiv aktiviti εn rεdכks inflameshn, it, εn rεdnes na di skin. Dat min se, dεn kin kכl dכn di imyun sistεm in rεspכns we i nכ want.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin fɔ tek mɛrɛsin

Dis rili impɔtant. Bifo yu disayd if abrocitinib fayn fɔ yu, yu dɔktɔ go nid fɔ no yu kɔmplit mɛdikal istri. Mek shɔ se yu tɛl yu dɔktɔ if yu gɛt ɛni wan pan dɛn tin ya:

Sik ɔ kɔndishɔn Speshal pɔynt dɛn we wi fɔ no bɔt
Infεkshכn stetכs Infεkshכn dεm we de kכmכt כ we de kam bak (e.g., chikinpoks, hεpi, TB (TB), fεnshכn כ baktriyal infεkshכn).
At sik ɛn prɔblɛm wit di blɔd vesel At sik, ay blɔd prɛshɔn, ay kɔlɔstrel, istri bɔt blɔd klɔt, strok.
Kansa If yu bin dɔn gɛt kansa bifo ɔ yu de gɛt tritmɛnt naw.
Ɔda tin dɛn we kin apin to pɔsin we sik Dayabitis, kidni ɔ liva sik, lɔng sik (asma, COPD), yay sik (e.g. katarakt), blɔd sɛl dɛn we nɔ de bɔku (rɛd, wayt, pletlɛt).
Pɔsin in yon ɛn di we aw i de liv in layf If yu gɛt bɛlɛ, yu de tray fɔ gɛt bɛlɛ, ɔ yu de gi pikin in bɛlɛ. If yu de smok. If yu jɔs gɛt di vaysin ɔ yu fɔ gɛt wan tumara bambay.
Alɛji dɛn we pɔsin kin gɛt If yu gɛt alɛji fɔ abrocitinib ɔ ɛni ɔda mɛrɛsin, it, ɔ day.

Aw ɛksaktɔli a kin yuz dis mɛrɛsin?

Fɔ mek yu gɛt di bɛst pan di mɛrɛsin, i rili impɔtant fɔ yuz am lɛk aw dɛn tɛl yu fɔ yuz am.

  • Dis na tablɛt we dɛn kin tek bay mɔt. Swɛla di tablɛt ɔl wit wan glas wata.
  • Di tin we impɔtant pas ɔl: Nɔ brok, krɔs, ɔ chew di tablɛt. Swɛla am ɔl.
  • Tray fɔ tek yu mɛrɛsin di sem tɛm ɛvride , jɔs lɛk aw yu dɔktɔ tɛl yu. Dis go ɛp fɔ kip di kɔnsɛntreshɔn fɔ di mɛrɛsin na yu blɔd na di sem lɛvɛl.
  • Yu kin tek dis bifo ɔ afta yu it. Bɔt if yu fil bad ɔ yu nɔs, tek di mɛrɛsin wit yu it.
  • Nɔ stɔp fɔ tek di mɛrɛsin te di dɔktɔ tɛl yu fɔ tek am.
  • Yu go gɛt spɛshal instrɔkshɔn liflet (`MedGuide`) wit dis mɛrɛsin frɔm di famasi. Rid am gud gud wan ɛvri tɛm.

Wetin fɔ du if yu mis wan doz fɔ mɛrɛsin?

If yu mis wan doz, tek am jɔs afta yu mɛmba. Bɔt if i nɔ rich 12 awa te yu tek yu nɛks doz we yu mɛmba, skip di doz we yu mis ɛn tek yu nɛks doz di tɛm we yu dɔn sɛtul. Nɔ ɛva tek tu dos wan tɛm.

Wetin a go du if a tek bɔku mɛrɛsin?

If yu tink se yu dɔn tek mɔ pas di doz we dɛn tɛl yu fɔ tek, nɔ delay. Wantɛm wantɛm, kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital , ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Ɔda mɛrɛsin dɛn we kin miks wit Abrocitinib

Sɔm mɛrɛsin dɛn kin afɛkt dɛnsɛf we dɛn tek dɛn togɛda. dis dεn kכl am `drug intarakshכn`. Na dat mek i rili impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek (inklud vaytamɛn, ɛbul mɛrɛsin, ɛn sɔpɔtmɛnt).

Mɛrɛsin dɛn we nɔ fɔ ɛva tek wit Abrocitinib

  • Abciximab we gɛt di sik
  • Anagrelide we dɛn kɔl
  • Silostazɔl we dɛn kɔl Cilostazol
  • Klɔpidogrɛl we dɛn kɔl
  • Dipiridamol we dɛn kɔl dipiridamol
  • Eptifibatide we dɛn kin yuz

  • Layf vaysin dɛn
  • Prasugrel we dɛn kɔl
  • Tikagrelɔr we dɛn kɔl
  • Tiklɔpidin we dɛn kɔl
  • Tirofiban we dɛn kɔl Tirofiban
  • Vorapaxar we de na di wɔl

Mɛrɛsin dɛn we dɛn fɔ tek ɔnda dɔktɔ advays nɔmɔ, bikɔs dɛn kin mek prɔblɛm.

  • Aspirin we dɛn kin yuz
  • Baricitinib, Tofacitinib, Upadacitinib (ɔda JAK inhibito dɛn) .
  • Bayolojikal mɛrɛsin dɛn (e.g. Adalimumab, Infliximab) .
  • Dabigatran we dɛn kɔl Dabigatran

  • Digoxin we dɛn kin yuz
  • Flukonazɔl we dɛn kɔl
  • Fluvoxamin we dɛn kɔl fluvoxamine
  • Rifampin bin de du am
  • Ɔda mɛrɛsin dɛn we de mek pɔsin nɔ ebul fɔ fɛt di sik

Impɔtant: Dis list nɔ kɔmplit. So, tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek.

Tin dɛn we yu fɔ tek tɛm wit mɔ we yu de tek di mɛrɛsin

  • Fɔ chɛk yu dɔktɔ ɔltɛm: Yu dɔktɔ go tɛl yu fɔ go to yu dɔktɔ ɔltɛm fɔ wach aw yu de fil ɛn aw yu mɛrɛsin de afɛkt yu. I go ɔda bak fɔ mek dɛn du blɔd tɛst fɔ chɛk tin dɛn lɛk yu blɔd sɛl dɛn ɛn di kɔlɔstrel lɛvɛl. Nɔ skip dɛn.
  • Risk fɔ infekshɔn: As wi bin dɔn tɔk, bikɔs dis mɛrɛsin de stɔp di imyun sistɛm, .Di risk fɔ gɛt infɛkshɔn kin bɔku. If yu gɛt sɔm kayn sik lɛk fiva, kol, kɔf, trot we de at, ɔ wund we nɔ de wɛl, nɔ fɔ mɛn yusɛf ɛn kɔl yu dɔktɔ wantɛm wantɛm.
  • Fɔ protɛkt yusɛf frɔm di san: Yu skin kin fil bad fɔ di san we yu de tek dis mɛrɛsin. So, nɔ fɔ go na do usay di san de shayn bad bad wan. If yu go na do, wɛr klos we de kɔba yu skin ɛn yuz gud tin fɔ protɛkt yusɛf frɔm di san.
  • Risk fɔ gɛt kansa: Stɔdi dɔn sho se pipul dɛm wae de tek dis mɛrɛsin kin gɛt sɔm kayn kansa (especially skin cancer) ɛn lymphoma smɔl. Nɔr frayd fɔ dis, bɔt tɔk to yu dɔktɔ bɔt dis risk ɛn ɛni nyu skin spat we yu notis.
  • Bεlε εn bεlε: Nɔ gi bεlε we yu de tek dis mεrεsin εn fכ at le wan de afta yu stכp. I kin afɛkt bak aw yu ebul fɔ gɛt bɛlɛ. If yu de wɔri bɔt dis, tɔk to yu dɔktɔ.

Di sayd ɛfɛkt dɛn we di mɛrɛsin kin gɛt

Lɛk ɔl mɛrɛsin, Abrocitinib kin mek yu gɛt sayd ɛfɛkt, pan ɔl we nɔto ɔlman kin gɛt am.

Siriɔs sayd ɛfɛkt dɛn we nid fɔ go to dɔktɔ wantɛm wantɛm
Alɛji dɛn we pɔsin kin gɛt Skin rash, it, swel na di lip/tɔng/fes, i nɔ izi fɔ blo.
Blɔd we de klɔt Leg pen, swel, wam, shɔt briz, chɛst pen.
At atak Tayt na di chɛst, sholda, an, nɔs, shɔt briz, swet.
Strok Di fes, an, ɔ leg kin swɛ/wik wantɛm wantɛm, i nɔ kin izi fɔ tɔk, i kin kɔnfyus, i nɔ kin izi fɔ waka.
Liva injuri Pen na di ɔp rayt say na di bɛlɛ, yu nɔ de want fɔ it, yu yay/skin de yɔlɔ, ɛn yu urine dak.
Sayd ɛfɛkt dɛm wae nɔr kin siriɔs, bɔt yu fɔ ripɔt to yu dɔktɔ if dɛn de mɔna yu
Akni we gɛt akni Akni na di fes ɔ bɔdi.
Prɔblɛm dɛn we de na di dijestiv sistɛm Nɔs, vɔmit, bɛlɛ pen.
Trot de at Trot kin at ɔ nɔ kin fil fayn.

Mɛsej we dɛn kin kɛr go na os

  • Abrocitinib na spɛshal mɛrɛsin we de afɛkt di imyun sistɛm ɛn dɛn kin yuz am fɔ trit atopik dɛmatitis.
  • Bifo yu bigin dis mɛrɛsin, i impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl yu mɛrɛsin ɛn ɔda mɛrɛsin dɛn we yu de tek.
  • Swɛla di tablɛt ɔl wit wata we yu nɔ brok, krɔs, ɔ chew.
  • Go to dɔktɔ kwik kwik wan if yu gɛt ɛni siriɔs sayn lɛk sayn fɔ infekshɔn (fiva, kɔf), i nɔ izi fɔ blo, yu chɛst de pen, ɔ yu de si chenj wantɛm wantɛm.
  • I rili impɔtant fɔ protɛkt yusɛf frɔm di san we yu de tek di mɛrɛsin ɛn fɔ mek yu dɔktɔ tɛl yu fɔ du di blɔd tɛst di rayt tɛm.
  • Nɔ stɔp fɔ tek di mɛrɛsin ɔ chenj di doz if yu dɔktɔ nɔ advays yu. If yu gɛt ɛnitin we de mɔna yu, tɔk bɔt am wit yu dɔktɔ.

Abrocitinib, abrocitinib, cibinqo, atopik dɛmatitis, atɔpik dɛmatitis, ɛkzema, skin sik, JAK inhibito, sayd ɛfɛkt dɛm
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 4 + 4 =